Enter assignee name

EPO Patents = 1

Forward Citations = 58

Loading Chart...

9 inventors (with patents filed for the assignee):

Daniel G Chain (3 out of 10 patents)

Noriaki Kinoshita (2 out of 2 patents)

Haruyasu Yamaguchi (2 out of 3 patents)

4. Masahiro Maeda (2 out of 2 patents)

5. Yuko Horikoshi (2 out of 2 patents)

6. Lester I Binder (1 out of 3 patents)

7. Yifan Fu (1 out of 1 patent)

8. Kristina Patterson (1 out of 1 patent)

9. Benjamin Chain (1 out of 2 patents)

6 patents: Sort by Forward Citations

1. 8703137 - Treatment of tauopathies (2014-04-22),

2. 8697076 - Antibodies selective for pathological tau dimers and prefibrillar pathological tau oligomers and their uses in treatment, diagnosis and monitoring of tauopathies (2014-04-15),

3. 8338379 - Monoclonal antibody and use thereof (2012-12-25),

4. 8173127 - Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof (2012-05-08),

5. 7901689 - Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies (2011-03-08),

6. 7807157 - Monoclonal antibodies and use thereof (2010-10-05),

Intellect Neurosciences Inc. is a biopharmaceutical company specializing in the development and commercialization of novel therapies for the treatment of Alzheimer's disease and other neurodegenerative disorders. The company's innovative approach focuses on targeting key pathways involved in the progression of these diseases, with a goal of improving outcomes for patients and their families.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

6 Patents

#946 in New York, NY

#2,570 in New York

#43,751 in US

New York, NY, United States of America

Intellect Neurosciences Inc.